Signaling Pathways - Eukaryotic elongation factors - Aurora Kinases - Hydroxylases - Tie-2
清除全部
- B6012 Pexmetinib (ARRY-614)Target: p38|Tie-2Summary: p38 MAPK 和 Tie2/Tek 受体酪氨酸激酶的双重抑制剂
- B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂
- A8711 DDD1074982 CitationTarget: Eukaryotic elongation factorsSummary: 新型的多级抗疟疾制剂
- B4904 ACTB-1003Target: VEGFR|FGFR|Tie-2|RSK|p70 S6KSummary: FGFR1抑制剂
- A8889 G-749Target: Aurora Kinases|FLT3|c-RETSummary: FLT3抑制剂
- B4751 L-MimosineTarget: HydroxylasesSummary: 铁螯合剂和脯氨酰-4-羟化酶抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- A8807 MK-8745Target: Aurora KinasesSummary: Aurora A的强效选择性抑制剂。
- A5979 Tie2 kinase inhibitor中文名: Tie2激酶抑制剂Target: Tie-2Summary: Tie-2(Tie2 )抑制剂
- A4489 TC-A 2317 hydrochlorideTarget: Aurora KinasesSummary: Aurora kinase A抑制剂